AN2 Therapeutics
ANTX
ANTX
35 hedge funds and large institutions have $10.5M invested in AN2 Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$68.8K | |
| 2 | +$56K | |
| 3 | +$24.7K | |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$16.8K |
| 5 |
Morgan Stanley
New York
|
+$15.9K |
Top Sellers
| 1 | -$49.4K | |
| 2 | -$48K | |
| 3 | -$26.5K | |
| 4 |
Two Sigma Investments
New York
|
-$19.1K |
| 5 |
Renaissance Technologies
New York
|
-$16.8K |
